The fate of granulosa cells following premature oocyte loss and the development of ovarian cancers

International Journal of Developmental Biology

Volumn 56, Issue 10-12, 2012, Pages 949-958

  Pitman, Janet L ^a   McNeilly, Alan S ^b   McNeilly, Judy R ^b   Hays, Laura E ^c   Bagby, Grover C ^c   Sawyer, Heywood R ^d   McNatty, Kenneth P ^a  

^a VICTORIA UNIVERSITY OF WELLINGTON   (New Zealand)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^d UNIVERSITY OF WYOMING SCHOOL OF PHARMACY   (United States)

Author keywords

Epithelium; Germ cell; Intraovarian tubule; Sex cord; Tumor

Indexed keywords

BONE MORPHOGENETIC PROTEIN 15; FANCONI ANEMIA GROUP D2 PROTEIN; FOLLITROPIN; INHIBIN;

AGE DISTRIBUTION; ARTICLE; BENIGN TUMOR; CARCINOGENESIS; CELL ACTIVITY; CELL DEATH; CELL DIFFERENTIATION; CELL FATE; CELL FUNCTION; CELL GROWTH; CELL LOSS; CELL STRUCTURE; CELLULAR DISTRIBUTION; CLINICAL FEATURE; CYSTADENOMA; DEVELOPMENTAL STAGE; DISEASE SEVERITY; EMBRYO CELL; EPITHELIUM CELL; EXPERIMENTAL ANIMAL; EXPERIMENTAL MOUSE; FEMALE; GENE INACTIVATION; GENE LOCATION; GENITAL SYSTEM; GERM CELL; GESTATIONAL AGE; GRANULOSA CELL; HORMONE RESPONSE; HORMONE SYNTHESIS; HUMAN; INVAGINATION; LUTEOMA; NONHUMAN; OOCYTE; ORGANOGENESIS; OVARY CANCER; OVARY CARCINOMA; OVARY FOLLICLE; OVIDUCT; PAPILLOMA; PRIORITY JOURNAL; RNA ANALYSIS; RNA STRUCTURE; SEX DIFFERENTIATION; SHEEP; SOLID TUMOR; SOMATIC CELL; STEROIDOGENESIS;

EID: 84873701960     PISSN: 02146282     EISSN: None     Source Type: Journal    
DOI: 10.1387/ijdb.120144jp     Document Type: Article

References (53)

1. AUERSPERG N. (2011). The origin of ovarian carcinomas: a unifying hypothesis. Int J Gynecol Pathol 30: 12-31.
2. BAGBY G.C. and ALTER B.P. (2006). Fanconi anemia. Semin Hematol 43: 147-156.
3. BAKER T.G. (1972). Oogenesis and ovarian development In: Reproductive Biology (Eds. H. Balin and S. Glasser). Excerpta Medica, Amsterdam, pp 398-437.
4. BOWEN N.J., WALKER L.D., MATYUNINA L.V., LOGANI S., TOTTEN K.A., BE-NIGNO B.B. and MCDONALD J.F. (2009). Gene expression profiling supports the hypothesis that human ovarian cancer epithelia are multipotent and capable of serving as ovarian cancer initiating cells. BMC Med Genomics 2: 71.
5. I) are devoid of secondary and tertiary follicles but contain many abnormal structures. Biol Reprod 49: 895-907.
6. BROOK M., SMITH J.W.S. and GRAY N.K. (2009). The DAZL and PABP families: RNA-binding proteins with interrelated roles in translational control in oocytes. Reproduction 137: 595-617.
7. DAO K.H., ROTELLI M.D., PETERSEN C.L., KAECH S., NELSON W.D., YATES J.E., NEWELL A.H., OLSON S.B., DRUKER B.J., and BAGBY G.C. (2012). FANCL ubiquitinates beta-catenin and enhances its nuclear function. Blood DOI: 10.1182/ blood-2011-11-388355
8. DONG J.L., ALBERTINI D.F., NISHIMORI K., KUMAR T.R., LU N. and MATZUK M.M. (1996). Growth differentiation factor-9 is required during early folliculogenesis. Nature 383: 531-535.
9. EPPIG J.J. (2001). Oocyte control of ovarian follicular development and function in mammals. Reproduction 122: 829-838.
10. FULLER P., CHU S., FIKRET S. and BURGER H. (2002). Molecular pathogenesis of granulosa cell tumours. Mol Cell Endocrinol 191: 89-96.
11. GALLOWAY S.M., MCNATTY K.P., CAMBRIDGE L.M., LAITINEN M.P.E., JUENGEL J.L., JOKIRANTA S., MCLAREN R.J., LUIRO K., DODDS K.G., MONTGOMERY G.W., BEATTIE A.E., DAVIS G.H. and RITVOS O. (2000). Mutations in an oocytederived growth factor gene (BMP15) cause increased ovulation rate and infertility in a dosage sensitive manner. Nat Genet 25: 279-283.
12. GILCHRIST R.B., RITTER L.J. and ARMSTRONG D.T. (2001). Mouse oocyte mitogenic activity is developmentally coordinated throughout folliculogenesis and meiotic maturation. Dev Biol 240: 289-298.
13. GUTHRIE M. (1958). Tumorigenesis in ovaries of mice after X irradiation. Cancer 11: 1226-1235.
14. HANRAHAN J.P., GREGAN S.M., MULSANT P., MULLEN M., DAVIS G.H., POWELL R. and GALLOWAY S.M. (2004). Mutations in the genes for oocyte-derived growth factors GDF9 and BMP15 are associated with both increased ovulation rate and sterility in Cambridge and Belclare sheep (Ovis aries). Biol Reprod 70: 900-909.
15. HOLZEL M., VAN DIEST P.J., BIER P., WALLISCH M., HOATLIN M.E., JOENJE H. and DE WINTER J.P. (2003). FANCD2 protein is expressed in proliferating cells of human tissues that are cancer-prone in Fanconi anaemia. J Pathol 201: 198-203.
16. HOUGHTALING S., TIMMERS, C., NOLL M., FINEGOLD M.J., JONES S.N., MEYN M.S. and GROMPE M. (2003). Epithelial cancer in Fanconi anemia complementa tion group D2 (Fancd2) knockout mice. Genes Dev 17: 2021-2035.
17. HOWELL J.S., MARCHANT J. and ORR J.W. (1954). Induction of ovarian tumours in mice with 9:10-dimethyl-1,2-benzanthracene. Br J Cancer 8: 635-646.
18. JUENGEL J.L., QUIRKE L.D., TISDALL D.J., SMITH P., HUDSON N.L. and MCNATTY K.P. (2000). Gene expression in abnormal ovarian structures of ewes homozygous for the Inverdale prolificacy gene. Biol Reprod 62: 1467-1478.
19. JUENGEL J.L., HUDSON N.L., HEATH D.A., SMITH P., READER K.L., LAWRENCE S.B., O'CONNELL A.R., LAITINEN M.P.E., CRANFIELD M., GROOME N.P., RITVOS, O. and MCNATTY K.P. (2002a). Growth differentiation factor 9 and bone morphogenetic protein 15 are essential for ovarian follicular development in sheep. Biol Reprod 67: 1777-1789.
20. JUENGEL J.L., SAWYER H.R., SMITH P.R., QUIRKE L.D., HEATH D.A., LUN S., WAKEFIELD S.T.J. and MCNATTY K.P. (2002b). Origins of follicular cells and ontogeny of steroidogenesis in ovine fetal ovaries. Mol Cell Endocrinol 191: 1-10.
21. KIM J., COFFEY D.M., CREIGHTON C.J., YU Z., HAWKINS S.M. and MATZUK M.M. (2012). High grade serous ovarian cancer arises from fallopian tube in a mouse model. Proc Natl Acad Sci USA 109: 3921-3926.
22. KRARUP T. (1970). Effect of 9,10-dimethyl-1,2-benzanthracene on the mouse ovary Ovarian tumorigenesis. Br J Cancer 24: 168-186.
23. KURMAN R.J. and SHIH I.-M. (2010). The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory. Am J Surg Pathol 34: 433-443.
24. KUMAR T.R., PALAPATTU G., WANG P., WOODRUFF T.K., BOIME I., BYRNE M.C. and MATZUK M.M. (1999). Transgenic models to study gonadotropin function: the role of follicle-stimulating hormone in gonadal growth and tumorigenesis. Mol Endocrinol 13: 851-865.
25. LUNDY T., SMITH P., O'CONNELL A., HUDSON N.L. and MCNATTY K.P. (1999). Populations of granulosa cells in small follicles of the sheep ovary. J Reprod Fertil 115: 251-262.
26. MATZUK M.M., FINEGOLD M.J., SU J.G., HSUEH A.J. and BRADLEY A. (1992). Alpha-inhibin is a tumour-suppressor gene with gonadal specificity in mice. Nature 360: 313-319.
27. MOHR U. (Ed.) (2001). International classification of rodent tumors: The mouse. Springer-Verlag, Berlin.
28. MCLEOD B.J., KYLE S.E., RAMSAY M.R. and MANLEY T.R. (1995). Hormone secretion patterns associated with increased ovulation rates or with ovarian dysfunction in Inverdale (FecX) ewes. Proc NZ Soc Anim Prod 55: 304-306.
29. MCNATTY K.P., JUENGEL J.L., WILSON T., GALLOWAY S.M. and DAVIS G.H. (2001). Genetic mutations influencing ovulation rate in sheep. Reprod Fertil Dev 13: 549-555.
30. MCNATTY K.P., HEATH D.A., LUNDY T., FIDLER A.E., QUIRKE L., O'CONNELL A., SMITH P., GROOME N. and TISDALL D.J. (1999). Control of early follicular development. J Reprod Fertil Suppl 54: 3-16.
31. MCNATTY K.P., QUIRKE L.D., FIDLER A., SMITH P., HEATH D.A. and TISDALL D. (2000). Ovarian development: fetus to puberty. In Hormones and Women's Health. (Ed. L.A. Salamonsen). Harwood Academic Publishers, pp 9-22.
32. MCNATTY K.P., SMITH P., HUDSON N.L., HEATH D.A., TISDALL D.J., O W.-S. and BRAW-TAL R. (1995). Development of the sheep ovary during fetal and early neonatal life and the effect of fecundity genes. J Reprod Fertil Suppl 49:113-121.
33. MCNEILLY J.R., SAUNDERS P.T.K., TAGGART M., CRANFIELD M., COOKE H.J. and MCNEILLY A.S. (2000). Loss of oocytes in Dazl knockout mice results in maintained ovarian steroidogenic function but altered gonadotrophin secretion in adult animals. Endocrinology 141: 4284-4294.
34. MCNEILLY J.R., MCNATTY K.P. and MCNEILLY A.S. (2010). The consequences of germ cell loss on ovarian development in neonatal Dazl knockout mice. Conf Proc Soc Reprod Fertil, Abstract 011.
35. MORA J.M., FENWICK M.A., CASTLE L., BAITHUN M., MOBBERLY M., CARZANIQA R., FRANKS S. and HARDY K. (2012). Characterization and significance of adhesion and junction-related proteins in mouse ovarian follicles. Biol Reprod 153: 1-14.
36. MORK L., MAATOUL D.M., MCMAHON J.A., GUO J.J., MCMAHON A.P. and CAPEL B. (2012). Temporal differences in granulosa cell specification in the ovary reflect distinct follicle fates in mice. Biol Reprod 86: 1-9.
37. MULLANY, L.K., FAN H.-Y., LIU Z., WHITE L.D., MARSHALL A., GUNARATNE P., ANDERSON M.L., CREIGHTON C.J., XIN L., DEAVERS M., WONG K.-K. and RICHARDS J.S. (2011). Molecular and functional characteristics of ovarian surface epithelial cells transformed by KrasG12D and loss of Pten in a mouse model in vivo. Oncogene 30: 3522-3536.
38. NICOL L., BISHOP S.C., PONG-WONG R., BENDIXEN C., HOLM L.E., RHIND S.M. and MCNEILLY A.S. (2009). Homozygosity for a single base-pair mutation in the oocyte-specific GDF9 gene results in sterility in Thoka sheep. Reproduction 138: 921-933.
39. NICHOLAS C.R., HASTON K.M. and PERA R.A.R. (2010). Intact fetal ovarian cord formation promotes mouse oocyte survival and development. BMC Dev Biol 10: 2.
40. PETERS H. (1978). Folliculogenesis in mammals. In: The Vertebrate Ovary (Ed. R.E. Jones). Plenum Press, pp 121-144.
41. PEJOVIC T., YATES J.E., LIU H.Y. et al., (2006). Cytogenetic instability in ovarian epithelial cells from women at risk of ovarian cancer. Cancer Res 66: 9017-9025.
42. RABINOVICI J. and JAFFE R.B. (1990). Development and regulation of growth and differentiated function in human and subprimate fetal gonads. Endocr Rev 11: 532-557.
43. ROBERTSON D.M., PRUYSERS E. and JOBLING T. (2007). Inhibin as a diagnostic marker for ovarian cancer. Cancer Lett 249: 14-17.
44. RUGGIU M., SPEED R., TAGGART M., MCKAY S.J., KILANOWSKI F., SAUNDERS P., DORIN J. and COOKE H.J. (1997). The mouse Dazla gene encodes a cytoplasmic protein essential for gametogenesis. Nature 389: 73-77.
45. SAWYER H.R., SMITH P., HEATH D.A., JUENGEL J.L., WAKEFIELD S.T.J. and MCNATTY K.P. (2002). Formation of ovarian follicles during fetal development in sheep. Biol Reprod 66: 1134-1150.
46. SMITH P., O W.-S., CORRIGAN K.A., SMITH T., LUNDY T., DAVIS G.H. and MCNATTY K.P. (1997). Ovarian morphology and endocrine characteristics of female sheep fetuses that are heterozygous or homozygous for the Inverdale prolificacy gene. Biol Reprod 57: 1183-1192.
47. THOMPSON L.H. and HINZ J.M. (2009). Cellular and molecular consequences of defective Fanconi anemia proteins in replication-coupled DNA repair: mechanistic insights. Mutat Res 668: 54-72.
48. VANDERHYDEN B.C. (2005). Loss of ovarian function and the risk of ovarian cancer. Cell Tissue Res 322: 117-124.
49. VAUGHAN S., COWARD J.I., BAST R.C. et al., (2011). Rethinking ovarian cancer: recommendations for improving outcomes. Nature Rev 11: 719-725.
50. VAN WAGENEN G. and SIMPSON M.E. (Eds.) (1965). Embryology of the ovary and testis Homo sapiens and Macaca mulatta. Yale University Press, New Haven.
51. WANG X.-Z., ANDREASSEN P.R. and D'ANDREA A.D. (2004). Functional interaction of monoubiqutinated FANCD2 and BRCA2/FANCD1 in chromatin. Mol Cell Biol 24: 5850-5862.
52. WU X., CHEN L., BROWN C.A., YAN C. and MATZUK M.M. (2004). Interrelationship of growth differentiation factor 9 and inhibin in early folliculogenesis and ovarian tumorigenesis in mice. Mol Endocrinol 18: 1509-1519.
53. WYSHAM W.Z., MHAWECH-FAUCEGLIA P., LI H., HAYS L., SYRIAC S., SKREPNIK T., WRIGHT J., PANDE N., HOATLIN M. and PEJOVIC T. (2012). BRCAness profile of sporadic ovarian cancer predicts disease recurrence. PLoS One 7: e30042.